What is the equity of US Neurosurgical Holdings this year?
US Neurosurgical Holdings has equity of 1.24 M USD this year.
US Neurosurgical Holdings Equity 2024
US Neurosurgical Holdings Equity
1.24 M USD
Ticker
USNU
ISIN
US90336K1016
In 2024, US Neurosurgical Holdings's equity was 1.24 M USD, a -51.9% increase from the 2.58 M USD equity in the previous year.
US Neurosurgical Holdings Aktienanalyse
What does US Neurosurgical Holdings do?
US Neurosurgical Holdings Inc (USN) is a diversified medical company that specializes in the development and marketing of innovative neurosurgical instruments and devices to improve patient care. History: The company's history dates back to 1996 when USN was founded to meet market needs in neurosurgical device supply. With a focus on quality, innovation, and customer satisfaction, USN became a pioneer in neurosurgical instruments and devices. Business model: USN's business model focuses on the manufacturing and marketing of products and services in the field of neurosurgical devices and instruments. The company aims to meet the needs of customers in this area and build long-term partnerships with them. The company works directly with customers such as neurosurgeons, hospitals, medical facilities, and healthcare institutions to ensure effective delivery of products and services. Divisions: USN operates multiple business divisions tailored to the needs of the healthcare sector. These include: 1. Neurosurgical instruments: USN offers a wide range of neurosurgical instruments that can be used for diagnostic or therapeutic work. The products include specialized microscopes, standard and custom instruments, as well as devices for spinal or brain surgery. The instruments are made of high-quality materials and meet the highest quality standards. 2. Neurodiagnostic equipment: Neurological examinations are essential for achieving good results. USN has a variety of biomedical devices used in this field, such as measurement probes, EEG equipment, IT systems, patient monitoring solutions, etc. 3. Neuro-implants: USN also offers a range of implants that can be used to treat various neurological impairments. These include ventriculoperitoneal shunts or hair-like implants. Products: USN offers a wide range of products, including: 1. Neurosurgical instruments: The company offers various types of neurosurgical instruments, including microscopes, standard and custom instruments. Popular products include standard and custom instrument sets used to support neurosurgical procedures. These sets are developed in close collaboration with neurosurgeons and other healthcare providers. 2. Neurodiagnostic equipment: USN offers a wide range of neurodiagnostic products, such as measurement probes, EEG equipment, IT systems, patient monitoring solutions, which can be used in various areas of the healthcare sector. 3. Neuro-implants: USN also offers a range of implants, including ventriculoperitoneal shunts for treating normal pressure hydrocephalus or implants that mimic the shape of hair. These implants are used to treat various neurological disorders. Conclusion: US Neurosurgical Holdings is a pioneer in neurosurgical device supply and has established itself as a significant industry leader. With a wide range of products and services, the company is well-positioned to meet the needs of customers in the healthcare sector. USN's focus on quality and customer satisfaction has made it the choice for many healthcare providers in need of state-of-the-art neurosurgical devices and instruments. US Neurosurgical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing US Neurosurgical Holdings's Equity
US Neurosurgical Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding US Neurosurgical Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating US Neurosurgical Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
US Neurosurgical Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in US Neurosurgical Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about US Neurosurgical Holdings Stock
What was the equity of US Neurosurgical Holdings compared to the previous year?
The equity of US Neurosurgical Holdings has increased/decreased by -51.9% decreased compared to the previous year.
What impact does a high equity have on investors of US Neurosurgical Holdings?
A high equity is advantageous for investors of US Neurosurgical Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of US Neurosurgical Holdings?
A low equity can be a risk for investors of US Neurosurgical Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of US Neurosurgical Holdings affect the company?
An increase in equity of US Neurosurgical Holdings can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of US Neurosurgical Holdings affect the company?
A reduction in equity of US Neurosurgical Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of US Neurosurgical Holdings?
Some factors that can affect the equity of US Neurosurgical Holdings include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of US Neurosurgical Holdings so important for investors?
The equity of US Neurosurgical Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can US Neurosurgical Holdings take to change the equity?
To change equity, US Neurosurgical Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does US Neurosurgical Holdings pay?
Over the past 12 months, US Neurosurgical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, US Neurosurgical Holdings is expected to pay a dividend of 0 USD.
What is the dividend yield of US Neurosurgical Holdings?
The current dividend yield of US Neurosurgical Holdings is .
When does US Neurosurgical Holdings pay dividends?
US Neurosurgical Holdings pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of US Neurosurgical Holdings?
US Neurosurgical Holdings paid dividends every year for the past 0 years.
What is the dividend of US Neurosurgical Holdings?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is US Neurosurgical Holdings located?
US Neurosurgical Holdings is assigned to the 'Health' sector.
Wann musste ich die Aktien von US Neurosurgical Holdings kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of US Neurosurgical Holdings from 6/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.
When did US Neurosurgical Holdings pay the last dividend?
The last dividend was paid out on 6/29/2024.
What was the dividend of US Neurosurgical Holdings in the year 2023?
In the year 2023, US Neurosurgical Holdings distributed 0 USD as dividends.
In which currency does US Neurosurgical Holdings pay out the dividend?
The dividends of US Neurosurgical Holdings are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von US Neurosurgical Holdings
Our stock analysis for US Neurosurgical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of US Neurosurgical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- US Neurosurgical Holdings Revenue
- US Neurosurgical Holdings Net Income
- US Neurosurgical Holdings P/E
- US Neurosurgical Holdings P/S
- US Neurosurgical Holdings EBIT
- US Neurosurgical Holdings Dividend
- US Neurosurgical Holdings Stocks
- US Neurosurgical Holdings Market capitalization
- US Neurosurgical Holdings Debt
- US Neurosurgical Holdings Liabilities
- US Neurosurgical Holdings Equity
- US Neurosurgical Holdings AAQS
- US Neurosurgical Holdings Employees
- US Neurosurgical Holdings ROE
- US Neurosurgical Holdings ROA
- US Neurosurgical Holdings ROCE
